Dr. Alejandro (Ale) Berlin obtained his Medical Degree as valedictorian from the Pontifical Catholic University of Chile. He underwent radiation oncology specialty training in Chile, Israel and Canada, which included a clinical-research fellowship and a MSc degree in genitourinary translational oncology at the University of Toronto. Currently, he is a staff clinician-scientist radiation oncologist at the Princess Margaret Cancer Centre (Toronto, Canada). His clinical practice focuses in the characterization of genitourinary malignancies with molecular and MR imaging, and novel applications of curative treatments combining systemic, stereotactic radiotherapy and MR-guided brachytherapy approaches. He is particularly interested in the design of innovative clinical trials, translational oncology, and the discovery of biomarkers using high-throughput genomics.
Dr. Berlin leads the clinical deployment of novel technologies such as AI-based radiotherapy planning methods for prostate cancer, and TECHNA’s development and application of technology to enable the routine collection of outcomes at the point of care. At this early stage of his career Ale aims to convey his clinical and research expertise towards improving and individualizing the treatments for patients with prostate cancer.